Skip to main content

Abstract

Rosacea is a common cutaneous disorder that has diverse clinical manifestations ranging from facial vascular hyperreactivity to sebaceous gland hyperplasia. It has been postulated that neurovascular interactions with release of proinflammatory and vasodilatory neuropeptides could be intergral to the pathogenesis of certain subtypes of this disorder. Stress, ultra-violet light or microbial antigens may stimulate release of these neurotransmitters and contribute to the flushing and erythema seen in some patients with rosacea. Study of the neurovascular interactive network in rosacea has provided understanding and insights in to the vascular reactivity which is a feature of the clinical disorder in some patients with rosacea.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 239.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Marks R. Concepts in the pathogenesis of rosacea. Br J Dermatol. 1968;80:170–7.

    Article  CAS  PubMed  Google Scholar 

  2. Powell FC. Rosacea. N Eng J Med. 2005;352:793–803.

    Article  CAS  Google Scholar 

  3. Wilkin JK. Rosacea: pathophysiology and treatment. Arch Dermatol. 1994;130:359–62.

    Article  CAS  PubMed  Google Scholar 

  4. Lonne-Rahn S, Nordlind K, Wiegleb Edstrõm D, Ros AM, Berg M. Laser treatment of rosacea. A pathoetiological study. Arch Dermatol. 2004;140:1345–9.

    Google Scholar 

  5. Griesemer R. Emotionally triggered disease in dermatological practice. Psychiar Ann. 1978;8:49–56.

    Google Scholar 

  6. Puchalski Z. Psychosomatic aspects in patients with alopecia areata, rosacea, and lichen rubber planus. Z Hautkr. 1983;58:1648–54.

    CAS  PubMed  Google Scholar 

  7. Steinhoff M, Stander S, Seeliger S, Ansel JC, Schmelz M, Luger T. Modern aspects of cutaneous neurogenic inflammation. Arch Dermatol. 2003;139:1479–88.

    Article  PubMed  Google Scholar 

  8. Legat FJ, Armstrong CA, Ansel JC. The cutaneous neurosensory system in skin disease. Adv Dermatol. 2002;18:91–109.

    PubMed  Google Scholar 

  9. Roosterman D, Goerge T, Schneider SW, Bunnett NW, Steinhoff M. Neuronal control of skin function: the skin as a neuroimmunoendocrine organ. Physiol Rev. 2006;86:1309–79.

    Article  CAS  PubMed  Google Scholar 

  10. Peters EMJ, Ericson ME, Hosoi J, Seiffert K, Hordinsky MK, Ansel JC, Paus R, Scholzen TE. Neuropeptide control mecahisms in cutaneous biology: physiological and clinical significance. J Invest Dermatol. 2006;126:1937–47.

    Article  CAS  PubMed  Google Scholar 

  11. Powell FC, Corbally N, Powell D. Substance P and rosacea. J Am Acad Dermatol. 1993;28(1):132–3.

    Article  CAS  PubMed  Google Scholar 

  12. Kϋrkçϋoğlu N, Alaybeyi F. Substance P immunoreactivity in rosacea. J Am Acad Dermatol. 1991;25:725–6.

    Article  Google Scholar 

  13. Wollina U. Rhinophyma – unusual expression of simple-type keratins and S100A in sebocytes and abundance of VIP receptor-positive dermal cells. Histol Histopathol. 1996;11:111–5.

    CAS  PubMed  Google Scholar 

  14. Piérard-Franchimont C, Quatresooz P, Piérard GE. Incidental control of rosacea by somatostatin. Dermatology. 2003;206:249–51.

    Article  PubMed  Google Scholar 

  15. Murphy A, Buchanan KD, Powell FC. Vasoactive intestinal peptide release is not a factor in roscaea. Br J Dermatol. 1997;137 Suppl 50:27.

    Google Scholar 

  16. Fimmel S, Glass E, Zouboulis CC. Neuropeptides and UV radiation are possible mediators of inflammation in rosacea. J Invest Dermatol. 2005;124(suppl):A16.

    Google Scholar 

  17. Zegaraska B, Lelińska A, Tyrakowski T. Clinical and experimental aspects of cutaneous neurogenic inflammation. Pharmacol Rep. 2006;58:13–21.

    Google Scholar 

  18. Lonne-Rahm S, Fischer T, Berg M. Stinging and rosacea. Acta Derm Venereol. 1999;79:460–1.

    Article  CAS  PubMed  Google Scholar 

  19. Scholzen T, Armstrong CA, Bunnett NW, Leger TA, Olerud JE, Ansel JC. Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems. Exp Dermatol. 1998;7:81–96.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Frank C. Powell .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

McAleer, M.A., Powell, F.C. (2014). Rosacea and Neuropeptides. In: Zouboulis, C., Katsambas, A., Kligman, A. (eds) Pathogenesis and Treatment of Acne and Rosacea. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69375-8_82

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-69375-8_82

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-69374-1

  • Online ISBN: 978-3-540-69375-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics